Allogene Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2017 to Q4 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Allogene Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2017 to Q4 2024.
  • Allogene Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending December 31, 2024 was 212M shares, a 25.8% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 212M +43.6M +25.8% Dec 31, 2024 10-K 2025-03-13
Q3 2024 210M +41.3M +24.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 209M +41.9M +25.1% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 170M +24.7M +17% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 169M +24.2M +16.8% Dec 31, 2023 10-K 2025-03-13
Q3 2023 168M +24.1M +16.8% Sep 30, 2023 10-K 2024-03-14
Q2 2023 167M +23.4M +16.3% Jun 30, 2023 10-K 2024-03-14
Q1 2023 146M +2.17M +1.51% Mar 31, 2023 10-K 2024-03-14
Q4 2022 144M +1.82M +1.27% Dec 31, 2022 10-K 2024-03-14
Q3 2022 144M +1.59M +1.12% Sep 30, 2022 10-K 2024-03-14
Q2 2022 144M +1.6M +1.13% Jun 30, 2022 10-K 2024-03-14
Q1 2022 144M +2.1M +1.48% Mar 31, 2022 10-K 2024-03-14
Q4 2021 143M +2.15M +1.53% Dec 31, 2021 10-K/A 2024-03-14
Q3 2021 142M +2.68M +1.92% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 142M +2.89M +2.07% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 141M +16.2M +12.9% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 140M +16.2M +13% Dec 31, 2020 10-K 2022-02-23
Q3 2020 140M +17.9M +14.7% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 139M +17.6M +14.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 125M +3.74M +3.07% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 124M +2.78M +2.29% Dec 31, 2019 10-K 2021-02-25
Q3 2019 122M +90.6M +290% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 122M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 122M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 121M +95.2M +363% Dec 31, 2018 10-K 2020-02-27
Q3 2018 31.3M Sep 30, 2018 10-Q 2018-11-21
Q4 2017 26.2M Dec 31, 2017 10-K 2019-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.